Peter Borchmann
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
Papers in
-
- Lymphoma Diagnosis and Treatment 6
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Viral-associated cancers and disorders 2
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Nathalie A. Johnson (4 shared papers)Abraham Avigdor (4 shared papers)Colm Keane (3 shared papers)Vladan Vučinić (3 shared papers)David Lavie (3 shared papers)Gareth P. Gregory (4 shared papers)John M. Timmerman (3 shared papers)Alex F. Herrera (3 shared papers)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Peter Borchmann
5 papers receiving 11 citations
Peers
Comparison fields: 5 of 6
- Pathology and Forensic Medicine 8
- Oncology 8
- Genetics 3
- Immunology 3
- Radiology, Nuclear Medicine and Imaging 2
Countries citing papers authored by Peter Borchmann
This map shows the geographic impact of Peter Borchmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Borchmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Borchmann more than expected).
Fields of papers citing papers by Peter Borchmann
This network shows the impact of papers produced by Peter Borchmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Borchmann. The network helps show where Peter Borchmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Borchmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 0 |
About Peter Borchmann
Peter Borchmann is a scholar working on Pathology and Forensic Medicine, Oncology, Neurology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 6 papers that have together received 11 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), CAR-T cell therapy research (3 papers), Viral-associated cancers and disorders (2 papers), Lung Cancer Treatments and Mutations (1 paper), CNS Lymphoma Diagnosis and Treatment (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (8 citations), Oncology (8 citations), Genetics (3 citations), Immunology (3 citations) and Radiology, Nuclear Medicine and Imaging (2 citations). Peter Borchmann has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Nathalie A. Johnson, Abraham Avigdor, Colm Keane, Vladan Vučinić, David Lavie, Gareth P. Gregory, John M. Timmerman, Alex F. Herrera, Wouter J. Plattel and Stephan Mathas. Their work appears in journals such as Blood and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.